NuVasive, a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced that it has signed a definitive agreement to acquire the Osteocel biologics business from Osiris Therapeutics, Inc.
NuVasive to acquire Osteocel biologics business from Osiris Therapeutics